Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression
- PMID: 34055858
- PMCID: PMC8160227
- DOI: 10.3389/fnut.2021.669846
Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression
Abstract
Emerging evidence is showing nutrition as a crucial factor in the high prevalence and incidence of neurodegenerative mental disorders. Preventive interventions on neuroinflammation seem to be able to interfere with neurodegeneration. Supplementation of essential nutrients, such as long-chain-polyunsaturated fatty acids, vitamin E and mineral elements, may minimize inflammation, enhancing antioxidative defense, and lowering the risk and incidence of age-related diseases, such as cardiovascular diseases and neurodegenerative diseases. This manuscript reviews the current evidence on the role of neuroinflammation in the pathophysiology of neurodegenerative and mental disorders, and preventive strategies for food supplementation in these neuropsychiatric diseases. Dietary supplementation-based strategies have been demonstrated to be effective in subjects with mild cognitive impairment, while weaker results have been obtained in patients with advance neurodegenerative disease. Adjunctive supplementation has also been demonstrated to improve depression, this being of marked benefit considering the comorbidity between cognitive impairment/dementia and depression. Further research is needed to improve the prescriptive precision of supplementation in patients, and to better understand potential interactions with clinical and pharmacokinetic factors.
Keywords: brain health; depression; diet; gut-brain axis; neuroinflammation.
Copyright © 2021 Businaro, Vauzour, Sarris, Münch, Gyengesi, Brogelli and Zuzarte.
Conflict of interest statement
JS has received either presentation honoraria, travel support, clinical trial grants, book royalties, or independent consultancy payments from: Integria Healthcare & MediHerb, Pfizer, Scius Health, Key Pharmaceuticals, Taki Mai, Fiji Kava, FIT-BioCeuticals, Blackmores, Soho-Flordis, Healthworld, HealthEd, HealthMasters, Kantar Consulting, Angelini Pharmaceuticals, Grunbiotics, Polistudium, Australian Natural Therapeutics Group, Research Reviews, Elsevier, Chaminade University, International Society for Affective Disorders, Complementary Medicines Australia, SPRIM, Terry White Chemists, ANS, Society for Medicinal Plant and Natural Product Research, Sanofi-Aventis, Omega-3 Center, the National Health and Medical Research Council, CR Roper Fellowship. EG has received grants or PhD fellowship support from Indena Italy SpA and Verdure Sciences. LB is employed in Polistudium, Italy, which received funds for editorial assistance from Angelini. GM has received either presentation honoraria, travel support, grants, or independent consultancy payments from Polistudium, Integria Healthcare, Qbiotics, Soho-Floris, and Pharmako Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- World Alzheimer Report. (2018). Available online at: https://www.alzint.org/resource/world-alzheimer-report-2018/
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
